Affiliation:
1. Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of City of Hope Duarte CA 91010 USA sdhawan@coh.org
Abstract
This chapter covers the advances made in epigenomics of type 2 diabetes, and how such work has elucidated the epigenetic underpinnings of this disease and its multiple complications. It discusses the developmental basis of diabetes, the causal role of gene–environment interactions in diabetes risk and pathogenesis, epigenetic dysregulation in multiple metabolic tissues, and the nanobiology of cell–cell communication in perpetuating such disease-relevant epigenetic changes. Finally, it delves into the translational potential of such studies on the development of biomarkers and therapeutic approaches for type 2 diabetes.
Publisher
The Royal Society of Chemistry